Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

884.54
+24.812.89%
Post-market: 887.402.86+0.32%19:59 EDT
Volume:3.40M
Turnover:2.97B
Market Cap:838.53B
PE:75.54
High:885.58
Open:859.66
Low:851.07
Close:859.73
Loading ...

Rpt-Lilly Exec Says Co Expects Negotiations With Some Insurers for Coverage of Zepbound in Sleep Apnea in the Second Half of the Year- Leerink Conference

THOMSON REUTERS
·
10 Mar

Corrected-Eli Lilly CFO Says Co Plans to Launch Diabetes and Weight Loss Drugs in New Countries Like China, India, Brazil and Mexico in 2025 (Not '2026') - Leerink Conference

THOMSON REUTERS
·
10 Mar

Novo Nordisk stock slides Monday on second-generation GLP-1 data

Yahoo Finance
·
10 Mar

CORRECTED-UPDATE 1-Eli Lilly plans launch of weight-loss drug in emerging markets in 2025, CFO says

Reuters
·
10 Mar

Eli Lilly Shares Down About 2% After Novo Nordisk's Next-Gen Obesity Drug Trial Data

THOMSON REUTERS
·
10 Mar

Lilly Exec Says Co Expects Negotiations With Some Insurers for Coverage of Zepbound in Sleep Apnea in the Second Half of the Year- Leerink Conference

THOMSON REUTERS
·
10 Mar

Eli Lilly CFO Says Co Plans to Launch Diabetes and Weight Loss Drugs in New Countries Like China, India, Brazil and Mexico in 2026 - Leerink Conference

THOMSON REUTERS
·
10 Mar

Pfizer Stock Up Almost 6% in 3 Months: Time to Buy, Sell or Hold?

Zacks
·
10 Mar

Eli Lilly Shares Reverse Course, Last Down 1.3% Premarket

THOMSON REUTERS
·
10 Mar

Novo Nordisk plunges following latest CagriSema data

Investing.com
·
10 Mar

Lilly's baricitinib delivered high rates of hair regrowth for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS study

PR Newswire
·
09 Mar

Eli Lilly and Company (LLY): Jim Cramer Says ‘Don’t Sell’ – A Visionary Stock to Hold!

Insider Monkey
·
08 Mar

Eli Lilly and Company (LLY): Among The Stocks With At Least $10 Million In Insider Sales Recently

Insider Monkey
·
08 Mar

Eli Lilly CEO's Total Compensation Rose 10% in 2024

Dow Jones
·
08 Mar

Eli Lilly & Co. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
08 Mar

Eli Lilly Says CEO David Ricks' 2024 Total Compensation Was $29.2 Mln - SEC Filing

THOMSON REUTERS
·
08 Mar

Eli Lilly (NYSE:LLY) Achieves Breakthrough Efficacy With EBGLYSS for Atopic Dermatitis in Long-Term Study

Simply Wall St.
·
08 Mar

Eli Lilly and Company (LLY): Jim Cramer Sees a ‘Big Moat’ with Weight Loss Drug

Insider Monkey
·
08 Mar

Eli Lilly Says Half of Eczema Patients Achieve Complete Skin Clearance at 3 Years With Ebglyss

MT Newswires Live
·
07 Mar

BRIEF-Lilly's Ebglyss Single Monthly Maintenance Injection Achieved Completely Clear Skin At Three Years In Half Of Patients With Moderate-To-Severe Atopic Dermatitis

Reuters
·
07 Mar